US › Healthcare

Clearpoint Neuro Inc (CLPT)

US · Healthcare · Medical Devices

$12.88-16.29%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$12.1M
Revenue YoY
+42.9%
Net profit
$-9.6M
Profit YoY
-58.5%
EPS
$-0.32
EPS estimate
$-0.27
Net margin
-78.8%

EPS came in at -0.32 against a street estimate of -0.27 — a miss of 18.5%.

Key statistics

Market cap
$461.2M
Forward P/E
12.1
P/B
23.78
Book value
$0.63
EPS (TTM)
$-1.00
52-week high
$30.10
52-week low
$8.27
50-day MA
$15.11
200-day MA
$14.22
Beta
1.27

Analyst view

Analysts rate Clearpoint Neuro Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $28.33.

Shareholding

Insiders
5.48%
Institutions
50.54%

Largest institutional holders

FundStake
BlackRock Inc6.94%
Mak Capital One LLC6.34%
Vanguard Group Inc5.89%
Vanguard Capital Management, LLC4.15%
Geode Capital Management, LLC2.35%
State Street Corp2.27%
Lane Generational LLC1.62%
The Goldman Sachs Group Inc1.55%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Clearpoint Neuro Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.